# EDGAR Filing Document

**Accession Number:** 0001704268
**File Stem:** 0001999371-25-021183
**Filing Date:** 2025-12
**Character Count:** 29056
**Document Hash:** db3eea23882d39a98506a564a8cf485d
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001999371-25-021183.hdr.sgml**: 20251223

**ACCESSION NUMBER**: 0001999371-25-021183

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D/A

**PUBLIC DOCUMENT COUNT**: 3

**FILED AS OF DATE**: 20251223

**DATE AS OF CHANGE**: 20251223

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** RECURSION PHARMACEUTICALS, INC.
- **CENTRAL INDEX KEY:** 0001601830
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 464099738
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-92498
- **FILM NUMBER:** 251602135

**BUSINESS ADDRESS:**
- **STREET 1:** 41S RIO GRANDE STREET
- **CITY:** SALT LAKE CITY
- **STATE:** UT
- **ZIP:** 84101
- **BUSINESS PHONE:** (385) 269-0203

**MAIL ADDRESS:**
- **STREET 1:** 41S RIO GRANDE STREET
- **CITY:** SALT LAKE CITY
- **STATE:** UT
- **ZIP:** 84101

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Recursion Pharmaceuticals, LLC
- **DATE OF NAME CHANGE:** 20140305
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Mubadala Investment Co PJSC
- **CENTRAL INDEX KEY:** 0001704268

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** C0
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A

**BUSINESS ADDRESS:**
- **STREET 1:** P.O. BOX 45005
- **CITY:** ABU DHABI
- **STATE:** C0
- **ZIP:** 00000
- **BUSINESS PHONE:** 971 2 413 0000

**MAIL ADDRESS:**
- **STREET 1:** P.O. BOX 45005
- **CITY:** ABU DHABI
- **STATE:** C0
- **ZIP:** 00000

## Exhibit 99.6

**EXHIBIT 99.6 - JOINT FILING AGREEMENT**

This joint filing agreement (this "Agreement") is made and entered into as of this 23rd day of December, 2025, by and among Mubadala Investment Company PJSC, Mamoura Diversified Global Holdings PJSC, MDC Capital Partners (Ventures) GP, LP, MDC Capital Partners (Ventures), LP, MIC Capital Management UK LLP, MC Alternative Solutions, LP and MIC Capital Partners (Ventures) Europe Parallel (Luxembourg) Aggregator SCSp.

The parties to this Agreement hereby agree to prepare jointly and file timely (and otherwise to deliver as appropriate) all filings on any Forms 3, 4, or 5 or Schedules 13D or 13G, and any and all amendments thereto and any other documents relating thereto (collectively, the "Filings") as required to be filed pursuant to the Securities Exchange Act of 1934, as amended. The parties to this Agreement further agree and covenant that each will fully cooperate with such other parties in the preparation, timely filing, and delivery of all such Filings.

IN WITNESS WHEREOF, the parties hereto have executed this agreement as of the date first set forth above.

Dated: December 23, 2025

Mubadala Investment Company PJSC

By: <u>/s/ Samer Halawa</u>

Name: Samer Halawa

Title: Chief Legal Officer

Mamoura Diversified Global Holdings PJSC

By: <u>/s/ Samer Halawa</u>

Name: Samer Halawa

Title: Chief Legal Officer

MDC Capital Partners (Ventures) GP, LP

By: <u>/s/ Rodney Cannon</u>

Name: Rodney Cannon

Title: Manager

MDC Capital Partners (Ventures), LP

By: <u>/s/ Rodney Cannon</u>

Name: Rodney Cannon

Title: Manager

MIC Capital Management UK LLP

By: <u>/s/ Rodney Cannon</u>

Name: Rodney Cannon

Title: General Counsel

MC Alternative Solutions, LP

By: <u>/s/ Rodney Cannon</u>

Name: Rodney Cannon

Title: Manager

MIC Capital Partners (Ventures) Europe Parallel (Luxembourg) Aggregator SCSp

By: <u>/s/ Rodney Cannon</u>

Name: Rodney Cannon

Title: Manager

## Ex-99

**<u>SCHEDULE 1</u>**

The following table sets forth all transactions in the Common Shares during the past sixty (60) days by the Reporting Persons. All such transactions were effected in the open market through brokers and the price per share excludes commissions. The Common Shares were purchased or sold in multiple transactions at prices indicated in the column Price Per Share ($). Where a price range is provided in the column Price Range ($), the price reported in that row's Price Per Share ($) column is a weighted average price. The Common Shares were purchased or sold in multiple transactions at prices between the price ranges indicated in the Price Range ($) column. The Reporting Persons will undertake to provide to the staff of the SEC, upon request, full information regarding the number of Common Shares purchased or sold at each separate price.

**<u>Fifteenth</u>**

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;**<u>Trade Date</u>** | &nbsp;&nbsp; **<u>Shares Purchased</u>** <br> **<u>(Sold)</u>** | &nbsp;&nbsp;**<u>Price Per Share ($)</u>** | &nbsp;&nbsp;**<u>Price Range ($)</u>** |
| &nbsp;&nbsp;12/18/2025 | &nbsp;&nbsp;(2481527) | &nbsp;&nbsp;4.5773 | &nbsp;&nbsp;4.44-4.96 |
| &nbsp;&nbsp;12/19/2025 | &nbsp;&nbsp;(5000000) | &nbsp;&nbsp;4.3159 | &nbsp;&nbsp;4.25-4.53 |
| &nbsp;&nbsp;12/22/2025 | &nbsp;&nbsp;(2084524) | &nbsp;&nbsp;4.3915 | &nbsp;&nbsp;4.30-4.53 |
| &nbsp;&nbsp;12/23/2025 | &nbsp;&nbsp;(3419876) | &nbsp;&nbsp;4.2389 | &nbsp;&nbsp;4.18-4.35 |

---

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**(Amendment No. 3)**

**RECURSION PHARMACEUTICALS, INC.**

*(Name of Issuer)*

**Class A Common Stock, $0.00001 par value per share**

*(Title of Class of Securities)*

**75629V104**

*(CUSIP Number)*

**Treasury & Investor Relations**<br>Mubadala Investment Company PJSC<br>P.O. Box 45005<br>Abu Dhabi C0 00000<br>971 2 413 0000

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**11/20/2024**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **75629V104** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Mubadala Investment Co PJSC** | Name of reporting person<br>**Mubadala Investment Co PJSC** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**WC** | Source of funds (See Instructions)<br>**WC** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**C0** | Citizenship or place of organization<br>**C0** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**0.00** | Aggregate amount beneficially owned by each reporting person<br>**0.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**0.0%** | Percent of class represented by amount in Row (11)<br>**0.0%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**CO** | Type of Reporting Person (See Instructions)<br>**CO** | |

---

**Comment for Reporting Person:** The calculation assumes that there is a total of 514,190,251 Common Shares outstanding as of November 24, 2025, as reported in the Prospectus Supplement filed by the Issuer pursuant to Rule 424(b)(7) with the Securities and Exchange Commission on November 26, 2025.

| **CUSIP No.** | **75629V104** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Mamoura Diversified Global Holding PJSC** | Name of reporting person<br>**Mamoura Diversified Global Holding PJSC** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**WC** | Source of funds (See Instructions)<br>**WC** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**C0** | Citizenship or place of organization<br>**C0** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**0.00** | Aggregate amount beneficially owned by each reporting person<br>**0.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**0.0%** | Percent of class represented by amount in Row (11)<br>**0.0%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**CO** | Type of Reporting Person (See Instructions)<br>**CO** | |

---

**Comment for Reporting Person:** The calculation assumes that there is a total of 514,190,251 Common Shares outstanding as of November 24, 2025, as reported in the Prospectus Supplement filed by the Issuer pursuant to Rule 424(b)(7) with the Securities and Exchange Commission on November 26, 2025.

| **CUSIP No.** | **75629V104** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**MDC Capital Partners (Ventures) GP, LP** | Name of reporting person<br>**MDC Capital Partners (Ventures) GP, LP** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**CAYMAN ISLANDS** | Citizenship or place of organization<br>**CAYMAN ISLANDS** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**7062869.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**7062869.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**7062869.00** | Aggregate amount beneficially owned by each reporting person<br>**7062869.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**1.4%** | Percent of class represented by amount in Row (11)<br>**1.4%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**PN** | Type of Reporting Person (See Instructions)<br>**PN** | |

---

**Comment for Reporting Person:** The calculation assumes that there is a total of 514,190,251 Common Shares outstanding as of November 24, 2025, as reported in the Prospectus Supplement filed by the Issuer pursuant to Rule 424(b)(7) with the Securities and Exchange Commission on November 26, 2025.

| **CUSIP No.** | **75629V104** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**MDC Capital Partners (Ventures), LP** | Name of reporting person<br>**MDC Capital Partners (Ventures), LP** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**CAYMAN ISLANDS** | Citizenship or place of organization<br>**CAYMAN ISLANDS** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**7062869.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**7062869.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**7062869.00** | Aggregate amount beneficially owned by each reporting person<br>**7062869.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**1.4%** | Percent of class represented by amount in Row (11)<br>**1.4%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**PN** | Type of Reporting Person (See Instructions)<br>**PN** | |

---

**Comment for Reporting Person:** The calculation assumes that there is a total of 514,190,251 Common Shares outstanding as of November 24, 2025, as reported in the Prospectus Supplement filed by the Issuer pursuant to Rule 424(b)(7) with the Securities and Exchange Commission on November 26, 2025.

| **CUSIP No.** | **75629V104** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**MIC Capital Management UK LLP** | Name of reporting person<br>**MIC Capital Management UK LLP** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X0** | Citizenship or place of organization<br>**X0** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**2581164.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**2581164.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**2581164.00** | Aggregate amount beneficially owned by each reporting person<br>**2581164.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**0.5%** | Percent of class represented by amount in Row (11)<br>**0.5%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IA** | Type of Reporting Person (See Instructions)<br>**IA** | |

---

**Comment for Reporting Person:** The calculation assumes that there is a total of 514,190,251 Common Shares outstanding as of November 24, 2025, as reported in the Prospectus Supplement filed by the Issuer pursuant to Rule 424(b)(7) with the Securities and Exchange Commission on November 26, 2025.

| **CUSIP No.** | **75629V104** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**MC Alternative Solutions, LP** | Name of reporting person<br>**MC Alternative Solutions, LP** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**CAYMAN ISLANDS** | Citizenship or place of organization<br>**CAYMAN ISLANDS** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**1388889.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**1388889.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**1388889.00** | Aggregate amount beneficially owned by each reporting person<br>**1388889.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**0.3%** | Percent of class represented by amount in Row (11)<br>**0.3%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**PN** | Type of Reporting Person (See Instructions)<br>**PN** | |

---

**Comment for Reporting Person:** The calculation assumes that there is a total of 514,190,251 Common Shares outstanding as of November 24, 2025, as reported in the Prospectus Supplement  filed by the Issuer pursuant to Rule 424(b)(7) with the Securities and Exchange Commission on November 26, 2025.

| **CUSIP No.** | **75629V104** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**MIC Capital Partners (Ventures) Europe Parallel (Luxembourg) Aggregator SCSp** | Name of reporting person<br>**MIC Capital Partners (Ventures) Europe Parallel (Luxembourg) Aggregator SCSp** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**N4** | Citizenship or place of organization<br>**N4** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**1192275.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**1192275.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**1192275.00** | Aggregate amount beneficially owned by each reporting person<br>**1192275.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**0.2%** | Percent of class represented by amount in Row (11)<br>**0.2%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**OO** | Type of Reporting Person (See Instructions)<br>**OO** | |

---

**Comment for Reporting Person:** The calculation assumes that there is a total of 514,190,251 Common Shares outstanding as of November 24, 2025, as reported in the Prospectus Supplement filed by the Issuer pursuant to Rule 424(b)(7) with the Securities and Exchange Commission on November 26, 2025.

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Class A Common Stock, $0.00001 par value per share

**(b) Name of Issuer:**
RECURSION PHARMACEUTICALS, INC.

**(c) Address of Issuer's Principal Executive Offices:**
41S Rio Grande Street, Salt Lake City, UT, 84101

This Amendment No. 3 (this "Amendment No. 3") amends and supplements the statement on Schedule 13D related to the Class A Common Stock, par value $0.00001 per share (the "Common Shares"), of Recursion Pharmaceuticals, Inc. (the "Issuer") which was originally filed with the Securities and Exchange Commission (the "SEC") on April 26, 2021 (the "Original 13D" and, as amended by this Amendment No. 3, this "Schedule 13D"). This Amendment No. 3 supplements Items 2, 3, 4 and 7 and amends and restates Items 5(a)-(c), and (e) as set forth below.

Except as set forth herein, in Amendment No. 1 filed with the Commission on November 4, 2021 (the "Amendment No. 1") and in Amendment No. 2 filed with the SEC on October 31, 2022 (the "Amendment No. 2"), the information in the Original 13D is unchanged and has been omitted from this Amendment No. 3. Unless otherwise defined herein, capitalized terms used herein shall have the meanings ascribed thereto in the Original 13D. This Amendment No. 3 is the final amendment to the Schedule 13D and constitutes an "exit filing" for the Reporting Persons.

**Item 4. Purpose of Transaction**

On March 31, 2023, MIC LP transferred the 1,388,889 Common Shares that it then held to MCAS. As a result, as of such time, MCAS directly held 1,388,889 Common Shares and MIC LP ceased to beneficially own any Common Shares.

In addition, the Issuer and Exscientia plc, a public limited company incorporated under the laws of England and Wales ("Exscientia"), entered into a transaction agreement, dated as of August 8, 2024, as amended (the "Transaction Agreement"). The Transaction Agreement provided that, subject to the conditions set forth therein, the Issuer would acquire the entire issued and to be issued share capital of Exscientia pursuant to a scheme of arrangement under Part 26 of the United Kingdom Companies Act 2006 (the "Scheme of Arrangement" and such transaction, the "Transaction").

The Transaction closed on November 20, 2024. Under the Transaction Agreement, pursuant to and following the effective time of the Scheme of Arrangement (the "Effective Time"), each ordinary share in Exscientia (each an "Exscientia Share") was automatically acquired by the Issuer in exchange for 0.7729 Common Shares.  Accordingly, at the Effective Time, MIC Europe received, in exchange for the 1,542,600 Exscientia Shares that it then held, 1,192,275 Common Shares. As a result, at the Effective Time, MIC Europe directly held 1,192,275 Common Shares and  MIC UK beneficially owned 2,581,164 Common Shares. In addition, between December 18, 2025, and the date hereof, Fifteenth sold a total of 12,985,927 Common Shares. As a result, as of the date hereof, Mubadala and Mamoura ceased to beneficially own any Common Shares.

The foregoing summary of the Transaction that was consummated pursuant to the Transaction Agreement does not purport to be complete and is qualified in its entirety by, the full text of the Current Report on Form 8-K filed by the Issuer with the SEC on November 20, 2024, and is incorporated herein by reference.

**Item 5. Interest in Securities of the Issuer**

**(a)**
See rows (11) and (13) of the cover page to this Schedule 13D for the aggregate number of Common Shares and percentage of Common Shares beneficially owned by each Reporting Person as of the date hereof. The aggregate percentage of Common Shares reported beneficially owned by each Reporting Person as of the date hereof is based upon 514,190,251 Common Shares outstanding as of November 24, 2025, as reported in the Prospectus Supplement filed by the Issuer pursuant to Rule 424(b)(7) with the SEC on November 26, 2025.

As of November 20, 2024, the Reporting Persons may have been deemed to beneficially own an aggregate of 22,629,960 Common Shares, which represented approximately 5.9% of the outstanding Common Shares as of such time. As of the date hereof, the Reporting Persons may be deemed to beneficially own an aggregate of 9,644,033 Common Shares, which represents approximately 1.9% of the outstanding Common Shares.

**(b)**
See rows (7) through (10) of the cover page to this Schedule 13D for the Common Shares as to which each Reporting Person has the sole or shared power to vote or direct the vote and sole or shared power to dispose or to direct the disposition.

**(c)**
Other than as described in Item 4 of this Amendment No. 3, no transactions in the Common Shares were effected by the Reporting Persons during the sixty (60) days before November 20, 2024. The transactions in the Common Shares effected by the Reporting Persons during the past sixty (60) days are set forth on Schedule 1 attached hereto and incorporated by reference herein.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Mubadala Investment Co PJSC

**Signature:** /s/ Samer Halawa

**Name/Title:** Samer Halawa, Chief Legal Officer

**Date:** 12/23/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Mamoura Diversified Global Holding PJSC

**Signature:** /s/ Samer Halawa

**Name/Title:** Samer Halawa, Chief Legal Officer

**Date:** 12/23/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** MDC Capital Partners (Ventures) GP, LP

**Signature:** /s/ Rodney Cannon

**Name/Title:** Rodney Cannon, Manager

**Date:** 12/23/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** MDC Capital Partners (Ventures), LP

**Signature:** /s/ Rodney Cannon

**Name/Title:** Rodney Cannon, Manager

**Date:** 12/23/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** MIC Capital Management UK LLP

**Signature:** /s/ Rodney Cannon

**Name/Title:** Rodney Cannon, General Counsel

**Date:** 12/23/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** MC Alternative Solutions, LP

**Signature:** /s/ Rodney Cannon

**Name/Title:** Rodney Cannon, Manager

**Date:** 12/23/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** MIC Capital Partners (Ventures) Europe Parallel (Luxembourg) Aggregator SCSp

**Signature:** /s/ Rodney Cannon

**Name/Title:** Rodney Cannon, Manager

**Date:** 12/23/2025